Receptors, Dopamine D2DopamineReceptors, Dopamine D1Receptors, Dopamine D3Dopamine AgonistsDopamine AntagonistsReceptors, Dopamine D4Receptors, DopamineDopaminergic NeuronsReceptors, Dopamine D5Dopamine AgentsDopamine Plasma Membrane Transport ProteinsCorpus StriatumBenzazepinesQuinpiroleRacloprideSalicylamidesSubstantia NigraDopamine Uptake InhibitorsMesencephalonTyrosine 3-MonooxygenaseSulpirideApomorphineHaloperidolOxidopamineNeostriatum2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineSpiperoneNucleus AccumbensLevodopaNeuronsDopamine beta-HydroxylaseCocaineAmphetamineRats, Sprague-DawleyDomperidoneVentral Tegmental AreaParkinsonian Disorders1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDopamine and cAMP-Regulated Phosphoprotein 32Parkinson DiseaseBehavior, AnimalMotor ActivityHomovanillic AcidMPTP PoisoningBromocriptineErgolinesParkinson Disease, SecondaryCaudate NucleusBrainTetrahydronaphthalenesCatalepsyPutamenMethamphetamineMicrodialysisAntipsychotic AgentsDose-Response Relationship, DrugRewardDihydroxyphenylalaninePyrrolidinesAntiparkinson AgentsPrefrontal CortexFlupenthixolVesicular Monoamine Transport ProteinsButaclamolBasal GangliaClozapine1-Methyl-4-phenylpyridiniumalpha-MethyltyrosineTropanesYawning3,4-Dihydroxyphenylacetic AcidRadioligand AssayLimbic SystemTegmentum MesencephaliStereotyped BehaviorAdrenergic AgentsRats, WistarCentral Nervous System StimulantsNomifensineNerve Tissue ProteinsNuclear Receptor Subfamily 4, Group A, Member 2PergolideAnalysis of VarianceSerotoninConditioning, OperantDyskinesia, Drug-InducedSynaptic TransmissionMice, Inbred C57BLLisuridePiperazinesalpha-SynucleinHyperkinesisBiogenic MonoaminesPositron-Emission TomographyBrain ChemistryCocaine-Related DisordersCatechol O-MethyltransferaseDextroamphetamineMice, Knockout